Development of indazole Rho-kinase (ROCK 1) inhibitors as potential antihypertensive agents

被引：0

作者：

Goodman, Krista Beaver ^{[1
]}

Dowdell, Sarah E. ^{[1
]}

Gaitanopoulos, Dimitri E. ^{[1
]}

Ivy, Robert ^{[1
]}

Sehon, Clark ^{[1
]}

Stavenger, Robert ^{[1
]}

Wang, Gren ^{[1
]}

Viet, Andrew Q. ^{[1
]}

Xu, Weiwei ^{[1
]}

Ye, Guosen ^{[1
]}

Semus, Simon F. ^{[2
]}

Evans, Christopher

Fries, Harvey E. ^{[3
]}

Jolivette, Larry J. ^{[3
]}

Jung, David K. ^{[1
]}

Wright, Lois L. ^{[4
]}

Smith, Gary K. ^{[4
]}

Behm, David J. ^{[5
]}

Bentley, Ross ^{[5
]}

Doe, Christopher P. ^{[5
]}

Hu, Erding ^{[5
]}

Lee, Dennis ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Dept Med Chem, King Of Prussia, PA 19406 USA

[2] GlaxoSmithKline Inc, Dept Computat & Struct Sci, King Of Prussia, PA 19422 USA

[3] GlaxoSmithKline Inc, Dept Drug Metab & Pharmacokinet, King Of Prussia, PA 19406 USA

[4] GlaxoSmithKline Inc, Screening & Compound Profiling, King Of Prussia, PA 19406 USA

[5] GlaxoSmithKline Inc, Cardiovasc & Urogenital CEDD, Biol, King Of Prussia, PA 19406 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

252-MEDI

引用

页数：1

共 50 条

[31] Peptide Substrates for Rho-Associated Kinase 2 (Rho-Kinase 2/ROCK2)
Kang, Jeong-Hun
Asai, Daisuke
Tsuchiya, Akira
Mori, Takeshi
Niidome, Takuro
Katayama, Yoshiki
PLOS ONE, 2011, 6 (07):
[32] Phosphorylation of Rho-associated kinase (Rho-kinase/ROCK/ROK) substrates by protein kinases A and C
Kang, Jeong-Hun
Jiang, Yuhua
Toita, Riki
Oishi, Jun
Kawamura, Kenji
Han, Aishan
Mori, Takeshi
Niidome, Takuro
Ishida, Masami
Tatematsu, Kenji
Tanizawa, Katsuyuki
Katayama, Yoshiki
BIOCHIMIE, 2007, 89 (01) : 39 - 47
[33] Association of Rho-kinase 1 (ROCK1) Gene Polymorphisms with Behcet's Disease
Oguz, Elif
Demiryurek, Abdullah Tuncay
Pehlivan, Yavuz
Kisacik, Bunyamin
Ozkara, Esma
Oztuzcu, Serdar
Alasehirli, Belgin
Onat, Ahmet Mesut
MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (04) : 419 - 426
[34] Potential Benefits of Rho-kinase Inhibition in Arterial Hypertension
Grisk, Olaf
CURRENT HYPERTENSION REPORTS, 2013, 15 (05) : 506 - 513
[35] Rho and Rho-kinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium
Anderson, SC
Stone, C
Tkach, L
SundarRaj, N
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 (04) : 978 - 986
[36] Rho-kinase as a potential target for the treatment of erectile dysfunction
Chitaley, K
Webb, RC
Mills, TM
DRUG NEWS & PERSPECTIVES, 2001, 14 (10) : 601 - 606
[37] Potential Benefits of Rho-kinase Inhibition in Arterial Hypertension
Olaf Grisk
Current Hypertension Reports, 2013, 15 : 506 - 513
[38] Rho-kinase, a potential therapeutic target for the treatment of hypertension
Hirooka, Y
Shimokawa, H
Takeshita, A
DRUG NEWS & PERSPECTIVES, 2004, 17 (08) : 523 - 527
[39] Rho Kinase (ROCK) Inhibitors for the Treatment of Glaucoma
Wu, Junhui
Wei, Jing
Chen, Haoliang
Dang, Yalong
Lei, Fang
CURRENT DRUG TARGETS, 2024, 25 (02) : 94 - 107
[40] IN SILICO COMPARISON OF RHO-KINASE INHIBITORS - PROTEIN DOCKING AFFINITY
Bandeira, Francisco
Hartono, Yossa Dwi
Venkatraman, Anandalakshmi
Gomes, Jose Alvaro Pereira
Peh, Gary S. L.
Mehta, Jodhbir S.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)

← 1 2 3 4 5 →